TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
OCS
Oculis
$
()
OCS
Oculis announces listing on Nasdaq Iceland Main Market
OCS
4/11/2024 - 08:58am
Oculis names Dr. Snehal Shah as President of Research & Development
OCS
4/10/2024 - 06:33am
Oculis announces 'positive' results from Phase 3 OPTIMIZE-1 trial of OCS-01
OCS
4/8/2024 - 06:34am
Oculis files $300M mixed securities shelf
OCS
4/1/2024 - 06:56am
Oculis price target lowered by $29 at Baird, here's why
OCS
3/19/2024 - 06:50am
Oculis provides update on progress of its late-stage clinical trials
OCS
2/28/2024 - 06:45am
Chardan lays out top 4 biotech picks for 2024
ALNY
,
RNA
,
LXEO
…
2/2/2024 - 08:52am
Oculis at H.C. Wainwright, here's why
OCS
12/20/2023 - 10:58am
Oculis announces first patient first visit in Phase 3 OPTIMIZE-2 trial of OCS-01
OCS
12/20/2023 - 06:33am
Oculis reports first patient visit in Phase 3 DIAMOND-1 trial of OCS-01
OCS
12/18/2023 - 06:44am
Oculis announces FPFV in Phase 2b RELIEF trial of licaminlimab
OCS
12/7/2023 - 06:35am
Chardan starts Oculis with Buy on diabetic macular edema potential
OCS
12/5/2023 - 05:58am
Oculis initiated with bullish view at Chardan
OCS
12/5/2023 - 05:36am
Oculis price target lowered to $21 from $24 at BofA
OCS
11/16/2023 - 07:25am
Oculis' OCS-01 eye drops meet primary and secondary Phase 3 endpoints in DME
OCS
10/10/2023 - 06:35am
dynamic_feed
Breaking News
search
Search
menu
Menu